Egg Consumption and Mortality Due to Cardiovascular Events

According to this study recently published in prestigious journal JAMA, eating too much cholesterol or eggs (which have a high concentration of it in the yolk) is significantly associated with a higher risk of cardiovascular events and all-cause mortality, with a typical dose/effect curve. According to the authors, this information should be considered for an update of current dietary guidelines.

colesterol ldl placas coronarias

Cholesterol is a common nutrient in any non-vegan diet and eggs are its main source. Recommendations on egg consumption have seen many different stages: from regarding it as “public enemy #1” to encouraging its consumption. This work seeks to put an end to controversy and deliver definitive information.

This analysis included 29,615 participants with a mean age of about 50 years old and a mean follow-up of 17.5 years.

For each additional 300 mg of dietary cholesterol consumed per day (very hard to measure in daily practice) or each additional half an egg per day (much easier to measure), there was a significant increase in cardiovascular events (adjusted hazard ratio [HR]: 1.17; 95% confidence interval [CI]: 1.09 to 1.26) and all-cause mortality (adjusted HR: 1.18; 95% CI: 1.10 to 1.26).


Read also: Strict LDL Monitoring Helps Reduce Plaque Volume.


The association between egg consumption and cardiovascular events or all-cause death was no longer significant after adjusting for dietary cholesterol consumption. This might mean that the problem lies in cholesterol itself, and that eggs are simply an easy way to measure it. There might not be any additional deleterious component (other than cholesterol) in eggs. Reducing egg consumption ultimately reduces cholesterol consumption.

Original Title: Associations of Dietary Cholesterol or Egg Consumption With Incident Cardiovascular Disease and Mortality.

Reference: Victor W. Zhong et al. JAMA. 2019;321(11):1081-1095.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...